What antibiotics are recommended for treating urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most effective antibiotics for treating urinary tract infections (UTIs) are nitrofurantoin, trimethoprim-sulfamethoxazole, and fosfomycin, with the choice of antibiotic depending on the severity of the infection and patient factors. When considering treatment options for UTIs, it's essential to prioritize the most recent and highest quality studies to ensure the best outcomes in terms of morbidity, mortality, and quality of life. The 2024 guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults, published in JAMA Network Open 1, provide clear recommendations for the duration of treatment based on the syndrome and antimicrobial class used. For adult cystitis, the recommended durations are:

  • Nitrofurantoin: 5 days
  • Trimethoprim-sulfamethoxazole (TMP/SMX): 3 days
  • Fosfomycin: single dose
  • Fluoroquinolones: 3 days Some key points to consider when treating UTIs include:
  • Completing the full course of antibiotics, even if symptoms improve
  • Drinking plenty of water during treatment
  • Consulting a healthcare provider if symptoms worsen or don't improve within 48 hours of starting treatment
  • Being aware of potential resistance concerns and adjusting treatment accordingly It's also important to note that the choice of antibiotic may depend on the severity of the infection, with more complicated UTIs potentially requiring different treatment options. Overall, the goal of treatment is to effectively manage the infection while minimizing the risk of adverse effects and promoting the best possible outcomes in terms of morbidity, mortality, and quality of life.

From the FDA Drug Label

The usual adult dosage in the treatment of urinary tract infections is 1 sulfamethoxazole and trimethoprim DS tablet every 12 hours for 10 to 14 days The recommended dosage for patients with documented infections is provided, and for the treatment of traveler’s diarrhea, the usual adult dosage is 1 sulfamethoxacin and trimethoprim DS (double strength) tablet or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 5 days. Ciprofloxacin, administered I. V. and/or orally, was compared to a cephalosporin for treatment of complicated urinary tract infections (cUTI) and pyelonephritis in pediatric patients 1 to 17 years of age The clinical success and bacteriologic eradication rates in the Per Protocol population were similar between ciprofloxacin and the comparator group

Antibiotics for UTI treatment:

  • Trimethoprim-sulfamethoxazole: 1 DS tablet every 12 hours for 10 to 14 days 2
  • Ciprofloxacin: may be used for complicated urinary tract infections, but the exact dosage is not specified for UTI treatment in the provided text 3

From the Research

Recommended Antibiotics for UTIs

The following antibiotics are recommended for treating urinary tract infections (UTIs) 4, 5, 6:

  • Nitrofurantoin
  • Fosfomycin
  • Pivmecillinam
  • Trimethoprim-sulfamethoxazole (when resistance levels are <20%)
  • Fluoroquinolones (although resistance is increasing)

Special Considerations

For complicated UTIs or those caused by multidrug-resistant organisms, the following antibiotics may be considered 4, 7:

  • Oral cephalosporins (e.g., cephalexin, cefixime)
  • β-lactams (e.g., amoxicillin-clavulanate)
  • Carbapenems (e.g., meropenem, imipenem-cilastatin/relebactam)
  • Aminoglycosides (e.g., plazomicin)
  • Ceftazidime-avibactam
  • Cefiderocol

Treatment Options for Specific Types of UTIs

  • For UTIs caused by ESBL-producing Enterobacteriales: nitrofurantoin, fosfomycin, pivmecillinam, amoxicillin-clavulanate, finafloxacin, and sitafloxacin 4
  • For UTIs caused by carbapenem-resistant Enterobacteriales: ceftazidime-avibactam, meropenem/vaborbactam, imipenem/cilastatin-relebactam, colistin, fosfomycin, aztreonam, and cefiderocol 4
  • For UTIs caused by multidrug-resistant Pseudomonas spp.: fluoroquinolones, ceftazidime, cefepime, piperacillin-tazobactam, carbapenems, and ceftolozane-tazobactam 4

Important Considerations

  • The choice of antibiotic should be based on the stratification of the UTI into complicated and uncomplicated, as well as upper and lower infections, and on specific risk factors (e.g., urinary tract catheter) 7
  • It is essential to use antibiotics wisely to avoid resistance development 4, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.